Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies

MILFORD, Massachusetts - Centerpiece of the is the establishment of The Waters Centre for BioMedical Mass Spectrometry

Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies, including Waters(R) SYNAPT High Definition MS(TM) (HDMS(TM)) system. This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry, validated by peer-reviewed publications, presentations at international conferences and an outreach education program.

At the core of the collaborative agreement is the establishment of ‘The Waters Centre for BioMedical Mass Spectrometry’ at the University of Warwick, a center of excellence in state-of-the-art MS techniques. This center will offer scientists worldwide an accessible resource to enable the adoption of cutting edge LC/MS-based techniques in life science.

“I believe that this partnership between a proven technology leader and a leading research focused University will provide a platform for the development of many exciting new projects,” said Prof. James Scrivens, Department of Biological Sciences, University of Warwick. “I look forward to being part of a team that delivers the benefits of our research to the wider community.”

“The University of Warwick is consistently ranked amongst the top research universities, with an historic track record in biological mass spectrometry,” said Brian Smith, Vice President, Mass Spectrometry Operations for the Waters Division. “However, this agreement is not based on reputation alone; it is based on a long-standing relationship with the University and Prof. James Scrivens in particular. Waters looks forward to taking this relationship to the next level through mutually beneficial research and a world-class educational resource for life scientists adopting cutting edge MS-based research strategies.”

For more information on MS technologies, Waters recently published a MS Primer complete with descriptions on modern MS practices, who uses mass spectrometers, the various types of MS, the importance of mass accuracy and resolutions, and a MS glossary. (www.waters.com/waters/nav.htm?cid=10073244)

About the University of Warwick

Among United Kingdom universities, Warwick is a unique, and uniquely successful, institution. Despite its relative youth it is now one of the UK’s leading universities, with an acknowledged reputation for excellence in research and teaching, for innovation and for links with business and industry. In the UK government’s 2008 Research Assessment Exercise, Warwick was ranked seventh overall in the UK, with 65% of the University’s research rates as 4-star (world-leading) or 3-star (internationally excellent).

About Waters Corporation (www.waters.com)

For 50 years, Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of US$1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, SYNAPT High Definition MS, and HDMS are trademarks of Waters Corporation.

Source: Waters Corporation

Jeff Tarmy, Corporate Communications Manager of Waters Corporation, +1-508-482-2268, jeff_tarmy at waters.com; or Peter Dunn, Press and Media Relations Manager of the University of Warwick, +44(0)24-76-529708, P.J.Dunn at warwick.ac.uk